Naquotinib mesylate (ASP8273 mesylate) is an orally available, mutant-selective and irreversible EGFR inhibitor, with IC50s of 8-33 nM toward EGFR mutants and 230 nM for EGFR.
Molecular Weight:
658.81
Purity:
>99%
CAS Number:
[1448237-05-5]
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted